After hours
Previous-day view · Thu Nov 5 close. You are previewing the previous trading day. Subscribe to see today live and every other date — Trader is $59/mo. Sign up Sign in
Transactions disclosed · Nov 5
1080

Latest filing Nov 5, 2026 Latest trade Nov 5, 2026

Disclosed buying · 14d
$970.12M

789 purchases across 234 tickers

Disclosed selling · 14d
$4.97B

4371 sales and dispositions

Tape lean · 14d
Heavy selling

Largest buy: ROL $49.96M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings
Most bought
Most sold

143,693 transactions

Insider Trades
Filed Transaction Issuer / asset Insider Qty / price Value Source Actions
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Class A Common Stock Gordon William B Director 700 shares @ $139.2 Direct ownership $97.44K SEC Form 4
Same filing as the row above Sale Nov 2, 2026 300 shares @ $133.3 Direct ownership $39.99K
Same filing as the row above Sale Nov 2, 2026 1,326 shares @ $137.6 Direct ownership $182.45K
Same filing as the row above Sale Nov 2, 2026 1,374 shares @ $138.4 Direct ownership $190.16K
Same filing as the row above Sale Nov 2, 2026 3,941 shares @ $135.53 Direct ownership $534.14K
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Crystal Adam President, R&d 1,100 shares @ $22.99 Direct ownership $25.29K SEC Form 4
Same filing as the row above Exercise Nov 2, 2026 Stock Option (Right to Buy) on Common Stock 5,000 shares @ $0 Direct ownership $0
Same filing as the row above Sale Nov 2, 2026 Common Stock 3,900 shares @ $22.26 Direct ownership $86.82K
Same filing as the row above Exercise Nov 2, 2026 5,000 shares @ $2.91 Direct ownership $14.55K
Nov 4, 2026 2-day lag Award Nov 2, 2026 Restricted Stock Unit on Common Stock Grech Patricia Y SVP, Chief Accounting Officer 4,806 shares @ $0 Direct ownership $0 SEC Form 4
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Newcomb Jessica Principal Accounting Officer 1,460 shares @ $22.98 Direct ownership $33.55K SEC Form 4
Same filing as the row above Sale Nov 2, 2026 5,571 shares @ $22.28 Direct ownership $124.11K
Nov 4, 2026 1-day lag Sale Nov 3, 2026 Common Stock Moran John V Chief Financial Officer 19,261 shares @ $25.57 Direct ownership $492.5K SEC Form 4
Nov 4, 2026 1-day lag Sale Nov 3, 2026 Common Stock Maduck Sean Other 8,617 shares @ $82.02 Direct ownership $706.76K SEC Form 4
Same filing as the row above Exercise Nov 3, 2026 Stock option (right to buy) on Common Stock 13,159 shares @ $0 Direct ownership $0
Same filing as the row above Sale Nov 3, 2026 Common Stock 4,542 shares @ $82.68 Direct ownership $375.51K
Same filing as the row above Exercise Nov 3, 2026 13,159 shares @ $8.27 Direct ownership $108.82K
Same filing as the row above Sale Nov 2, 2026 11,841 shares @ $81.42 Direct ownership $964.07K
Same filing as the row above Exercise Nov 2, 2026 Stock option (right to buy) on Common Stock 11,841 shares @ $0 Direct ownership $0
Same filing as the row above Exercise Nov 2, 2026 Common Stock 11,841 shares @ $8.27 Direct ownership $97.93K
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Kleinerman Christian EVP, Product Management 10,000 shares @ $306.01 Direct ownership $3.06M SEC Form 4
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Vieira Roberto Wandenkolk President, Oncology 6,657 shares @ $80.73 Direct ownership $537.44K SEC Form 4
Same filing as the row above Exercise Nov 2, 2026 8,333 shares @ $21.63 Direct ownership $180.24K
Same filing as the row above Sale Nov 2, 2026 1,676 shares @ $81.52 Direct ownership $136.63K
Same filing as the row above Exercise Nov 2, 2026 Stock option (right to buy) on Common Stock 8,333 shares @ $0 Direct ownership $0
Kleinerman Christian EVP, Product Management
Sale
Calculated transaction value
$3.06M
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Quantity / price
10,000 shares @ $306.01